Proactive Investors - Run By Investors For Investors

finnCap sets 145p price target on Cello Health shares in wake of recent ‘good’ full-year 2018 results

“We reiterate our view that the market backdrop for Cello’s technically based, strategic advisory services is strong and defensive, supporting good growth prospects,” finncap's analysts said
Healthcare
In late afternoon trading, Cello Health shares were changing hands at 124.50p each, up 0.4% on Tuesday’s close

finnCap has set a target price of 145p per share on Cello Health PLC (LON:CLL) in the wake of the global healthcare-focused advisory group’s recent full-year results.

In a note to clients, analysts at the ‘house’ broker said: “Cello reported a good set of FY 2018 results with net fees +2%, PBT +6%, EPS +14% (aided by lower tax), DPS +10% and net cash £6.3m up from £1.6m last year.”

READ: Cello is confident of a strong performance in 2019

They pointed out that Cello’s 2017 acquisitions continued to perform well and the Health division broadened and deepened its client offering once again.

Looking forward, the analysts added, the focus will remain on growing the group’s presence in the US and leveraging Signal’s digital capability into the healthcare sector.

They concluded: “We reiterate our view that the market backdrop for Cello’s technically based, strategic advisory services is strong and defensive, supporting good growth prospects.”

In late afternoon trading, Cello Health shares were changing hands at 124.50p each, up 0.4% on Tuesday’s close.

View full CLL profile View Profile

Cello Health PLC Timeline

Video
April 11 2019
Big Picture
March 22 2019

Related Articles

books
May 22 2019
Here we take a closer look at Bloomsbury Publishing PLC (LON:BMY)
pills
March 22 2019
The healthcare-focused advisory group boasts good levels of forward bookings thanks to several new business wins at the beginning of 2019
Live Company
June 13 2019
In June 2019 the company signed a five-year deal to create tours themed around properties owned by children’s television network Nickelodeon

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use